RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best ...

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the ...

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading Metasite TM, today announced the launch of a stand-alone Patient ...

MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced the appointment of Kelly Johnston McKee as Vice President, ...

Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global capabilities to execute clinical trials and accelerate ...

Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...

MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced it has been named a finalist for two prestigious SCOPE ...

PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...

A Morrisville company that helps people participate in clinical trials from home through a software platform has exited its state incentive agreement to create 250 jobs in the Triangle, blaming ...

“After an extensive review of opportunities available to Science 37, we believe that eMed provides the greatest value to our stockholders, customers, patients, and employees” said David Coman, Chief ...